Circulating IGF1 and IGF2 and SNP genotypes in men and pregnant and non-pregnant women

Endocrine Connections

Volumn 3, Issue 3, 2014, Pages 138-149

  Gatford, K L ^a   Heinemann, G K ^a   Thompson, S D ^a   Zhang, J V ^a   Buckberry, S ^a   Owens, J A ^a   Dekker, G A ^a   Roberts, C T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Human; IGF1; IGF2; Pregnancy; SNP genotype

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGE; ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; NORMAL HUMAN; PLACENTA DEVELOPMENT; PREGNANCY; PREGNANT WOMAN; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84960479501     PISSN: None     EISSN: 20493614     Source Type: Journal    
DOI: 10.1530/EC-14-0068     Document Type: Article

References (67)

1. YuH,Mistry J,NicarMJ, KhosraviMJ, Diamandis A, vanDoorn J & Juul A. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. Journal of Clinical Laboratory Analysis 1999 13 166-172. (doi:10.1002/(SICI)1098-2825(1999)13:4!166::AID-JCLA5O3.0.CO;2-X)
2. Juul A, Bang P, Hertel N, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K & Skakkebaek N. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. Journal of Clinical Endocrinology and Metabolism 1994 78 744-752. (doi:10.1210/jcem.78. 3.8126152)
3. Brabant G, von zur Mühlen A, Wüster C, Ranke MB, Kratzsch J, KiessW, Ketelslegers JM,Wilhelmsen L,HulthénL, SallerB et al. Seruminsulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results froma multicenter study. Hormone Research in Paediatrics 2003 60 53-60. (doi:10.1159/000071871)
4. Yamamoto H, Sohmiya M, Oka N & Kato Y. Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinologica 1991 124 497-500.
5. Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, Korner A, Obermayer-Pietsch B, Hubener C, Dahlgren J et al. Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. Journal of Clinical Endocrinology and Metabolism 2014 99 1712-1721. (doi:10.1210/jc.2013-3059)
6. Merimee TJ, Zapf J, Hewlett B & Cavalli-Sforza LL. Insulin-like growth factors in pygmies. The role of puberty in determining final stature. New England Journal of Medicine 1987 316 906-911. (doi:10.1056/ NEJM198704093161503)
7. Juul A, Dalgaard P, BlumWF, Bang P, Hall K, Michaelsen KF, Muller J & Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. Journal of Clinical Endocrinology and Metabolism 1995 80 2534-2542. (doi:10.1210/jcem.80.8.7543116)
8. Gargosky SE, Moyse KJ, Walton PE, Owens JA, Wallace JC, Robinson JS & Owens PC. Circulating levels of insulin-like growth factors increase and molecular forms of their serum binding proteins change with human pregnancy. Biochemical and Biophysical Research Communications 1990 170 1157-1163. (doi:10.1016/0006-291X(90)90514-N)
9. Hills FA, English J & Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. Journal of Endocrinology 1996 148 303-309. (doi:10.1677/joe.0.1480303)
10. Wilson DM, Bennett A, Adamson GD, Nagashima RJ, Liu F, DeNatale ML, Hintz RL & Rosenfeld RG. Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. Journal of Clinical Endocrinology and Metabolism 1982 55 858-861. (doi:10.1210/jcem-55-5-858)
11. Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G & Evain-BrionD.Placental growthhormone levels innormalpregnancy and in pregnancies with intrauterine growth retardation. Pediatric Research 1993 34 439-442. (doi:10.1203/00006450-199310000-00011)
12. Naylor KE, Iqbal P, Fledelius C, Fraser RB & Eastell R. The effect of pregnancy on bone density and bone turnover. Journal of Bone and Mineral Research 2000 15 129-137. (doi:10.1359/jbmr.2000.15.1.129)
13. Black AJ, Topping J, Durham B, Farquharson RG&Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. Journal of Bone and Mineral Research 2000 15 557-563. (doi:10.1359/jbmr.2000.15.3.557)
14. Monaghan JM, Godber IM, Lawson N, Kaur M, Wark G, Teale D & Hosking DJ. Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Annals of Clinical Biochemistry 2004 41 220-226. (doi:10.1258/000456304323019596)
15. Olausson H, Lof M, Brismar K, Lewitt M, Forsum E & Sohlstrom A. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Hormone Research 2008 69 99-106. (doi:10.1159/000111813)
16. Sowers M, Scholl T, Grewal J, Chen X & Jannausch M. IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. Journal of Clinical Endocrinology and Metabolism 2001 86 5898-5903. (doi:10.1210/jcem.86.12.8114)
17. Sferruzzi-Perri AN, Owens JA, Pringle KG & Roberts CT. The neglected role of insulin-like growth factors in thematernal circulation regulating fetal growth. Journal of Physiology 2011 589 7-20. (doi:10.1113/ jphysiol.2010.198622)
18. Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS & Roberts CT. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 2006 147 3344-3355. (doi:10.1210/en.2005-1328)
19. Sferruzzi-Perri AN, Owens JA, Standen P, Taylor RL, Heinemann GK, Robinson JS & Roberts CT. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. American Journal of Physiology 2007 292 E668-E676. (doi:10.1152/ajpendo.00320.2006)
20. Sferruzzi-Perri AN, Owens JA, Standen P, Taylor RL, Robinson JS & Roberts CT. Early pregnancy maternal endocrine insulin-like growth factor I programs the placenta for increased functional capacity throughout gestation. Endocrinology 2007 148 4362-4370. (doi:10.1210/en.2007-0411)
21. McIntyre HD, Serek R, Crane DI, Veveris-Lowe T, Parry A, Johnson S, LeungKC,HoKK,BougoussaM,HennenGet al. Placental growthhormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. Journal of Clinical Endocrinology and Metabolism 2000 85 1143-1150.
22. Vella A, Bouatia-Naji N, Heude B, Cooper J, Lowe C, Petry C, Ring S, Dunger D, Todd J & Ong K. Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes. Diabetologia 2008 51 811-815. (doi:10.1007/s00125-008-0970-7)
23. Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C & Kittles RA. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 2007 28 2154-2159. (doi:10.1093/carcin/bgm190)
24. Patel AV,Cheng I, Canzian F, LeMarchand L, ThunMJ, BergCD, Buring J, Calle EE,Chanock S, Clavel-Chapelon F et al. IGF-1, IGFBP-1, andIGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the breast and prostate cancer cohort consortium (BPC3). PLoS ONE 2008 3 e2578. (doi:10.1371/journal.pone.0002578)
25. Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B & Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. International Journal of Cancer 2010 126 180-190. (doi:10.1002/ijc.24674)
26. Qian B, Zheng H, Yu H & Chen K. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women. Breast Cancer Research and Treatment 2011 130 217-226. (doi:10.1007/s10549-011- 1552-9)
27. de Alencar SA & Lopes JCD. A comprehensive in silico analysis of the functional and structural impact of SNPs in the IGF1R gene. Journal of Biomedicine & Biotechnology 2010 2010 Article ID 715139. (doi:10.1155/2010/715139)
28. Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, Mugianesi E, Centurelli M, Franceschi C & Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. Journal of Clinical Endocrinology and Metabolism 2003 88 3299-3304. (doi:10.1210/jc.2002-021810)
29. Albani D, Batelli S, Polito L, Vittori A, Pesaresi M, Gajo G, De Angeli S, Zanardo A, Gallucci M & Forloni G. A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study. BMC Geriatrics 2009 9 19. (doi:10.1186/1471-2318-9-19)
30. Albani D, Mazzuco S, Polito L, Batelli S, Biella G, Ongaro F, Gustafson DR, Antuono P, Gajo G, Durante E et al. Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso LongevaK TRELONG). Aging Male 2011 14 257-264. (doi:10.3109/13685538.2011.607521)
31. BiongM, GramI, Brill I, Johansen F, Solvang H, Alnaes G, FagerheimT, Bremnes Y, Chanock S, Burdett L et al. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Medical Genomics 2010 3 9. (doi:10.1186/1755-8794-3-9)
32. Stanilova S, IvanovaM, Karakolev I, Stoilov R, Rashkov R & Manolova I. Association of C3179G/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus. Lupus 2013 22 1388-1393. (doi:10.1177/0961203313502860)
33. Chia VM, Sakoda LC, Graubard BI, Rubertone MV, Chanock SJ, Erickson RL & McGlynn KA. Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes. Cancer Epidemiology, Biomarkers & Prevention 2008 17 721-726. (doi:10.1158/ 1055-9965.EPI-07-0768)
34. Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). Journal of Pediatric Endocrinology & Metabolism 1999 12 231-249.
35. Laron Z. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones 2008 7 24-27. (doi:10.14310/horm.2002.1111034)
36. Ekstrom TJ, Cui H, Li X& Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 1995 121 309-316.
37. Wu H-K, Squire JA, Song Q & Weksberg R. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochemical and Biophysical Research Communications 1997 233 221-226. (doi:10.1006/bbrc. 1997.6431)
38. Monk D, Sanches R, Arnaud P, Apostolidou S, Hills FA, Abu-Amero S, Murrell A, Friess H, Reik W, Stanier P et al. Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Human Molecular Genetics 2006 15 1259-1269. (doi:10.1093/hmg/ddl041)
39. Buckberry S, Bianco-Miotto T, Hiendleder S & Roberts CT. Quantitative allele-specific expression and DNA methylation analysis of H19, IGF2 and IGF2R in the human placenta across gestation reveals H19 imprinting plasticity. PLoS ONE 2012 7 e51210. (doi:10.1371/journal. pone.0051210)
40. Maher ER & Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited. Journal of Clinical Investigation 2000 105 247-252. (doi:10.1172/JCI9340)
41. Heijmans BT, Kremer D, Tobi EW, Boomsma DI & Slagboom PE. Heritable rather than age-related environmental and stochastic factors dominate variation in DNA methylation of the human IGF2/H19 locus. Human Molecular Genetics 2007 16 547-554. (doi:10.1093/hmg/ddm010)
42. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE & Day INM. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. International Journal of Obesity and Related Metabolic Disorders 1997 21 822-825. (doi:10.1038/sj.ijo.0800483)
43. Petry CJ, Seear RV, Wingate DL, Manico L, Acerini CL, Ong KK, Hughes IA & Dunger DB. Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy. Diabetes 2011 60 3090-3096. (doi:10.2337/db11-0689)
44. Roth SM, Schrager MA, Metter EJ, Riechman SE, Fleg JL, Hurley BF & Ferrell RE. IGF2 genotype and obesity in men and women across the adult age span. International Journal of Obesity and Related Metabolic Disorders 2002 26 585-587. (doi:10.1038/sj.ijo.0801927)
45. Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, Briggs R, Day IN & Cooper C. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age and Ageing 2002 31 468-470. (doi:10.1093/ ageing/31.6.468)
46. Keku T, Vidal A, Oliver S, Hoyo C, Hall I, Omofoye O, McDoom M, Worley K, Galanko J, Sandler R et al. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes & Control 2012 23 1127-1138. (doi:10.1007/s10552-012-9981-2)
47. Vafiadis P, Bennett ST, Todd JA, Grabs R & Polychronakos C. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 1998 83 2933-2939. (doi:10.1210/jcem.83.8.5048)
48. Gomes MVM, Soares MR, Pasqualim-Neto A, Marcondes CR, Lôbo RB & Ramos ES. Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Hormone & IGF Research 2005 15 360-362. (doi:10.1016/j.ghir.2005.06.016)
49. Kaku K, Osada H, Seki K & Sekiya S. Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth. Acta Paediatrica 2007 96 363-367. (doi:10.1111/j.1651-2227.2006.00120.x)
50. Adkins RM, Somes G, Morrison JC, Hill JB, Watson EM, Magann EF & Krushkal J. Association of birth weight with polymorphisms in the IGF2, H19, and IGF2R genes. Pediatric Research 2010 68 429-434. (doi:10.1203/PDR.0b013e3181f1ca99)
51. Heude B, Ong KK, Luben R, Wareham NJ & Sandhu MS. Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. Journal of Clinical Endocrinology and Metabolism 2007 92 2734-2738. (doi:10.1210/jc.2006-1948)
52. Petry C, Ong K, Barratt B, Wingate D, Cordell H, Ring S, Pembrey M, Team TAS, Reik W, Todd J et al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genetics 2005 6 22. (doi:10.1186/1471-2156-6-22)
53. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, Maher ER & Reik W. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Human Molecular Genetics 2004 13 247-255. (doi:10.1093/hmg/ddh013)
54. Kho EM, McCowan LME, North RA, Roberts CT, Chan E, Black MA, Taylor RS & Dekker GA. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. Journal of Reproductive Immunology 2009 82 66-73. (doi:10.1016/j.jri.2009.04.011)
55. Sykes SD, Pringle KG, Zhou A, Dekker GA, Roberts CT, Lumbers ER & Consortium S . Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. Journal of Human Hypertension 2014 28 133-139. (doi:10.1038/jhh.2013.51)
56. Owens PC, Johnson RJ, Campbell RG & Ballard FJ. Growth hormone increases insulin-like growth factor (IGF-I) and decreases IGF-II in plasma of growing pigs. Journal of Endocrinology 1990 124 269-275. (doi:10.1677/joe.0.1240269)
57. Carr JM, Owens JA, Grant PA,Walton PE, Owens PC &Wallace JC. Circulating insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and tissuemRNAlevels of IGFBP-2 and IGFBP-4 inthe ovinefetus. Journal of Endocrinology 1995 145 545-557. (doi:10.1677/joe.0.1450545)
58. Giudice LC, Farrell EM, Pham H, Lamson G & Rosenfeld RG. Insulinlike growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. Journal of Clinical Endocrinology and Metabolism 1990 71 806-816. (doi:10.1210/jcem-71-4-806)
59. Hossenlopp P, Segovia B, Lassarre C, Roghani M, BredonM& Binoux M. Evidence of enzymatic degradation of insulin-like growth factorbinding proteins in the 150K complex during pregnancy. Journal of Clinical Endocrinology and Metabolism 1990 71 797-805. (doi:10.1210/ jcem-71-4-797)
60. Hasegawa T, Hasegawa Y, Takada M & Tsuchiya Y. The free form of insulin-like growth factor I increases in circulation during normal human pregnancy. Journal of Clinical Endocrinology and Metabolism 1995 80 3284-3286. (doi:10.1210/jcem.80.11.7593439)
61. Boldt HB & Conover CA. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Hormone & IGF Research 2007 17 10-18. (doi:10.1016/j. ghir.2006.11.003)
62. Yan X, Baxter RC & Firth SM. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. Journal of Clinical Endocrinology and Metabolism 2010 95 1412-1420. (doi:10.1210/jc.2009-2277)
63. Eriksson L, Frankenne F, Eden S, Hennen G & Vonschoultz B. Growth-hormone secretory profiles in pregnancy - lack of pulsatility for the secretion of the placental variant. British Journal of Obstetrics and Gynaecology 1989 96 949-953. (doi:10.1111/j.1471-0528.1989. tb03352.x)
64. Frankenne F, Closset J,Gomez F, ScippoM, Smal J & HennenG. The physiology of growth hormones (GHs) in pregnant women and partial characterisationof theplacentalGHvariant. Journal ofClinical Endocrinology and Metabolism 1988 66 1171-1180. (doi:10.1210/jcem-66-6-1171)
65. Hall K, Enberg G, Hellem E, Lundin G, Ottosson-Seeberger A, Sara V, Trygstad O & Öfverholm U. Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1984 59 587-594. (doi:10.1210/jcem-59-4-587)
66. Han VK, Bassett N, Walton J & Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Journal of Clinical Endocrinology and Metabolism 1996 81 2680-2693. (doi:10.1210/jcem.81.7.8675597)
67. Iñiguez G, González CA, Argandoña F, Kakarieka E, Johnson MC & Cassorla F. Expression and protein content of IGF-I and IGF-I receptor in placentas from small, adequate and large for gestational age newborns. Hormone Research in Paediatrics 2010 73 320-327. (doi:10.1159/000308163)